Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants
Launched by HUMANA CO.LTD. · Feb 28, 2014
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • nonbreastfed eutrophic infants of corresponding gestational age
- • presence of a positive family allergic anamnesis in parents or siblings (atopic eczema, allergic rhinitis or bronchial asthma)
- Exclusion Criteria:
- • children with serious disease,
- • breastfed children
- • children fed another formula then the ones used
About Humana Co.Ltd.
Humana Co., Ltd. is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on enhancing patient outcomes, Humana specializes in conducting high-quality clinical trials across various therapeutic areas, including oncology, cardiology, and neurology. The organization is committed to ethical practices, regulatory compliance, and collaboration with healthcare professionals, ensuring that trials are designed to meet the highest standards of scientific rigor. Humana's mission is to facilitate the development of safe and effective therapies that address unmet medical needs, ultimately contributing to the improvement of global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ostrava Vitkovice, , Czech Republic
Patients applied
Trial Officials
Jan Bozensky, MD
Principal Investigator
Vitkovice Hospital, Ostrava, Czech Republic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials